What happened
CXI Healthcare Technology Group disclosed a subsidiary's supply contract with Huamei Haolian Medical Technology (Beijing) Co., Ltd., worth US$4.99M, about 13.56% of the subsidiary's recent annual revenue, running through Jul 2027.
For context, this single contract equals about 13.56% of the subsidiary's most recent annual revenue.
| Counterparty | Huamei Haolian Medical Technology (Beijing) Co., Ltd. |
|---|---|
| Contract value | US$4.99M |
| vs. subsidiary revenue | 13.56% |
| Through | Jul 2027 (from Jul 2026) |
| Filed | 2026-07-27, Supply contract signed (subsidiary) |
| Source | DART rcept 20260727900691 → open original filing |
Source: DART. Information only, not investment advice.